Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology
- PMID: 2327757
- PMCID: PMC171547
- DOI: 10.1128/AAC.34.1.179
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology
Abstract
With 120 clinical isolates of the Bacteroides fragilis group, a comparison of rates of resistance to selected antimicrobial agents by using two susceptibility tests was performed in two medical institutions. The broth microdilution method produced MICs significantly lower than those determined by the agar dilution method. With ceftizoxime and cefoxitin, 88 and 18%, respectively, of the MICs were greater than or equal to 2 twofold dilutions apart. These differences in MIC results produced major interpretive discrepancies for ceftizoxime and cefoxitin, whereas no significant differences in resistance rates were noted for clindamycin and metronidazole.
Similar articles
-
Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.J Clin Microbiol. 1987 Dec;25(12):2317-21. doi: 10.1128/jcm.25.12.2317-2321.1987. J Clin Microbiol. 1987. PMID: 3480894 Free PMC article.
-
Evaluation of microdilution trays (sensititre) for antimicrobial susceptibility testing of Bacteroides fragilis.Med Microbiol Immunol. 1978 Oct 20;165(3):147-51. doi: 10.1007/BF02123171. Med Microbiol Immunol. 1978. PMID: 723780
-
Survey of Bacteroides fragilis group susceptibility patterns in Canada.Antimicrob Agents Chemother. 1992 Feb;36(2):343-7. doi: 10.1128/AAC.36.2.343. Antimicrob Agents Chemother. 1992. PMID: 1605600 Free PMC article.
-
Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota.Rev Inst Med Trop Sao Paulo. 1996 Sep-Oct;38(5):329-35. doi: 10.1590/s0036-46651996000500003. Rev Inst Med Trop Sao Paulo. 1996. PMID: 9293074 Review.
-
Mechanisms of Bacteroides fragilis resistance to metronidazole.Infect Genet Evol. 2018 Oct;64:156-163. doi: 10.1016/j.meegid.2018.06.020. Epub 2018 Jun 21. Infect Genet Evol. 2018. PMID: 29936037 Review.
Cited by
-
Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.Antimicrob Agents Chemother. 1992 Sep;36(9):2051-3. doi: 10.1128/AAC.36.9.2051. Antimicrob Agents Chemother. 1992. PMID: 1416899 Free PMC article.
-
Current antimicrobial therapy of anaerobic infections.Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):999-1011. doi: 10.1007/BF01967790. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1295770 Review.
-
Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.Antimicrob Agents Chemother. 1991 Oct;35(10):2057-64. doi: 10.1128/AAC.35.10.2057. Antimicrob Agents Chemother. 1991. PMID: 1759827 Free PMC article.
-
Containing cefoxitin costs through a program to curtail use in surgical prophylaxis.Can J Infect Dis. 1993 Sep;4(5):275-8. doi: 10.1155/1993/875916. Can J Infect Dis. 1993. PMID: 22346462 Free PMC article.
-
Susceptibility testing of anaerobic bacteria: myth, magic, or method?Clin Microbiol Rev. 1991 Oct;4(4):470-84. doi: 10.1128/CMR.4.4.470. Clin Microbiol Rev. 1991. PMID: 1747863 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical